Table 2.
Parameter | Univariate HR | Multivariate HR (Model 1) | Multivariate HR (Model 2) |
---|---|---|---|
Age | 1.03*** [1.02,1.04] | 1.12** [1.03,1.20] | 1.04*** [1.02,1.06] |
Ethnicity (Indigenous) | 1.45** [1.10,1.92] | 0.65 [0.097,4.42] | |
Past ulcer | 1.43* [1.06,1.92] | 2.70 [0.36,20.34] | |
Peripheral vascular disease | 2.04*** [1.54,2.71] | 2.41 [0.47,12.41] | |
Retinopathy | 1.32 [0.97,1.78] | 5.13 [0.54,48.97] | |
Macrovascular disease | 1.78*** [1.34,2.36] | 12.11* [1.65,88.66] | 1.36 [0.92,2.01] |
Chronic Kidney Disease | 1.24*** [1.16,1.33] | 1.63* [1.03,2.60] | 1.22*** [1.11,1.34] |
Blood HbA1c | 0.92* [0.85,0.99] | 1.24 [0.98,1.5] | 1.00 [0.92,1.08] |
Blood Haemoglobin | 0.99*** [0.98,0.99] | 0.95* [0.90,0.99] | 0.99 [0.98,1.00] |
Serum Albumin | 0.97** [0.95,0.99] | 1.31* [1.06,1.63] | 0.97* [0.94,0.995] |
Serum Alkaline Phosphatase | 1.004*** [1.002,1.005] | 1.007 [0.99,1.02] | |
Urine Albumin Creatinine Ratio | 1.002*** [1.001,1.002] | 1.00 [0.999,1.007] | |
Non-compliance | 2.038** [1.276,3.255] | 4.43 [0.33,58.51] |
Hazard Ratio; 95% confidence intervals in brackets; * P < 0.05, ** P < 0.01, *** P < 0.001; Model 1 included variables with P < 0.01 in univariate analysis. Model 2 included variables with P < 0.01 in Model 1. Gender, remoteness, diabetes duration, ulcer duration, ulcer site, ulcer area, Wagner Grade, amputation, hypertension, smoking, alcohol or other drug abuse, neuropathy, retinopathy, inflammation markers, lipid levels, gamma-glutamyl trans-peptidase and insulin therapy were not associated with mortality